Patent · US Expired

Tetracycline-inducible transcriptional activator and tetracycline-regulated transcription units

US5654168A · kind A · utility

79Cited by
2References
33Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 15, 1994
Grant dateAug 5, 1997
Priority date
Expiry dateJul 15, 2014

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/006
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Nucleic acid molecules and proteins useful for regulating the expression of genes in eukaryotic cells and organisms in an inducible manner are disclosed. In the regulatory system of the invention, transcription of a tet operator-linked nucleotide sequence is stimulated by a transcriptional activator fusion protein composed of two polypeptides, a first polypeptide which binds to tet operator sequences in the presence of tetracycline or a tetracycline analogue and a second polypeptide which directly or indirectly activates transcription in eukaryotic cells. In one embodiment, the fusion protein comprises a mutated Tet repressor operatively linked to a transcriptional activation polypeptide, such as a portion of herpes simplex virus virion protein 16. In the absence of an inducing agent (tetracycline or a tetracycline analogue), transcription of the tet operator-linked nucleotide sequence remains uninduced. In the presence of the inducing agent, transcription of the tet operator-linked nucleotide sequence is stimulated by the transactivator fusion protein of the invention. Novel transcription units which allow for coordinate or independent tetracycline-regulated expression of two or m…

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.